Two nano-based drug delivery systems recently were chosen for new supply deals. TheraTarget announced it will produce polymer-drug conjugate products for Rexahn Pharmaceuticals, which is in Phase II trials for...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)